
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Non-bacterial thrombotic endocarditis laboratory findings
Introduction
Overview
Overview
There are no specific diagnostic laboratory findings associated with non-bacterial thrombotic endocarditis. Tests are usually conducted to detect the underlying cause of NBTE and differentiate it from infective endocarditis;.
Laboratory Findings
Laboratory Findings
- There are no specific diagnostic laboratory findings associated with non-bacterial thrombotic endocarditis.
- The following laboratory tests are usually conducted to detect the underlying cause of NBTE and differentiate it from infective endocarditis;
Hematological and coagulation studies
- CBC: may show neutrophilia and anemia
- Prothrombin time, partial thromboplastin time, fibrinogen, thrombin time, D-dimers, and cross-linked fibrin degradation products (abnormal values may depict DIC).
Blood cultures
- Multiple blood cultures (minimum to 3 blood cultures prior to antibiotic use) to rule out infective endocarditis and other infectious etiologies[1].
- Antinuclear antibodies (SLE screening)
- Anti-dsDNA antibodies (SLE confirmation and to monitor the progress of disease and lupus nephritis)
- Anti-Smith antibodies
- Anti-RNP
- Antiphospholipid antibodies
- Anticardiolipin antibodies (associated with an increased risk of cardiac abnormalities)
- Anti-Ro/SSA
- Anti-La/SSB
- False-positive serology in the form of VDRL is also common in SLE
Inflammatory markers
The following inflammatory markers are often elevated
Polymerase chain reaction (PCR)
References
References
- ↑ “Libman-Sacks Endocarditis Clinical Presentation: History, Physical Examination”.
- ↑ Hojnik M, George J, Ziporen L, Shoenfeld Y (April 1996). “Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome”. Circulation. 93 (8): 1579–87. doi:10.1161/01.cir.93.8.1579. PMID 8608627.
- ↑ Cervera R (2004). “Coronary and valvular syndromes and antiphospholipid antibodies”. Thromb. Res. 114 (5–6): 501–7. doi:10.1016/j.thromres.2004.06.026. PMID 15507284.
- ↑ Prendergast BD (June 2004). “Diagnostic criteria and problems in infective endocarditis”. Heart. 90 (6): 611–3. doi:10.1136/hrt.2003.029850. PMC 1768277. PMID 15145855.
- ↑ Millar B, Moore J, Mallon P, Xu J, Crowe M, Mcclurg R, Raoult D, Earle J, Hone R, Murphy P (2001). “Molecular diagnosis of infective endocarditis–a new Duke’s criterion”. Scand. J. Infect. Dis. 33 (9): 673–80. doi:10.1080/00365540110026764. PMID 11669225.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aisha Adigun, B.Sc., M.D.[2]
